Clinical Trial Update: Post Market Observational Trial for the PerQdisc Nucleus Replacement Device

View source ↗

Summary

Post-market observational trial NCT05105490 evaluating the PerQdisc Nucleus Replacement Device has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease
• Low Back Pain

Drugs mentioned

• PerQdisc Nucleus Replacement Device

Snippet

Sponsor: Spinal Stabilization Technologies | Conditions: Degenerative Disc Disease, Chronic Low-back Pain | Status: WITHDRAWN